Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Penumbra Inc (PEN)

Penumbra Inc (PEN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,520,257
  • Shares Outstanding, K 35,074
  • Annual Sales, $ 547,410 K
  • Annual Income, $ 48,460 K
  • 60-Month Beta 0.64
  • Price/Sales 12.29
  • Price/Cash Flow 153.32
  • Price/Book 13.79

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.48
  • Number of Estimates 3
  • High Estimate -0.43
  • Low Estimate -0.57
  • Prior Year 0.27
  • Growth Rate Est. (year over year) -277.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.48 +14.34%
on 06/15/20
195.00 -4.14%
on 07/13/20
+19.22 (+11.46%)
since 06/12/20
3-Month
161.11 +16.02%
on 05/27/20
195.00 -4.14%
on 07/13/20
+17.08 (+10.06%)
since 04/14/20
52-Week
121.80 +53.46%
on 03/23/20
195.00 -4.14%
on 07/13/20
+17.23 (+10.15%)
since 07/12/19

Most Recent Stories

More News
Worldwide Transcatheter Embolization and Occlusion Devices Industry to 2027 - Featuring BTG, Cook Medical & Pfizer Among Others

, /PRNewswire/ -- The report has been added to offering.

ABT : 94.82 (+1.86%)
BSX : 35.22 (+2.26%)
EW : 71.22 (+6.00%)
MDT : 94.65 (+2.03%)
MMSI : 43.29 (-0.80%)
PEN : 186.92 (+0.55%)
PFE : 35.23 (+0.06%)
SXMDF : 24.9000 (+5.73%)
SYK : 182.71 (+2.73%)
TRUMF : 37.1500 (+0.19%)
Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership

--Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer

PEN : 186.92 (+0.55%)
Penumbra, Inc. to Present at the William Blair 40th Annual Growth Stock Conference

, /PRNewswire/ -- Penumbra, Inc. today announced that its management team is scheduled to present at the William Blair 40th Annual Growth Stock Conference on .

PEN : 186.92 (+0.55%)
Penumbra, Inc. Announces Pricing of Offering of Common Stock

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced the pricing of an underwritten public offering of 753,012 shares of its common...

PEN : 186.92 (+0.55%)
Penumbra, Inc. Announces Launch of Offering of $100,000,000 of Shares of its Common Stock

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced that it has commenced an underwritten public offering of of shares of its common...

PEN : 186.92 (+0.55%)
Penumbra, Inc. Announces Virtual 2020 Annual Meeting of Stockholders

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that the format for its 2020 Annual Meeting of Stockholders (the "Annual Meeting") has been changed from an in-person meeting to a virtual-only...

PEN : 186.92 (+0.55%)
Penumbra Announces Management Transition

, /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced that , President, will transition from Penumbra, and joins as Executive...

PEN : 186.92 (+0.55%)
Neurovascular Devices Market Size, Share & Trends Analysis Report By Therapeutic Applications, By Device, By Region And Segment Forecasts, 2020 - 2027

, /PRNewswire/ -- Read the full report: The global neurovascular devices market size is anticipated to reach by 2027, registering a CAGR of 5.6% over the forecast period. Rising demand for minimally...

MDT : 94.65 (+2.03%)
MCRPF : 5.3500 (+2.88%)
PEN : 186.92 (+0.55%)
Penumbra: 1Q Earnings Snapshot

ALAMEDA, Calif. (AP) _ Penumbra Inc. (PEN) on Thursday reported first-quarter net income of $1.4 million.

PEN : 186.92 (+0.55%)
Penumbra, Inc. Reports First Quarter 2020 Financial Results

, May 7, 2020 /PRNewswire/ -- Penumbra, Inc.(NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended .

PEN : 186.92 (+0.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade PEN with:

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

2nd Resistance Point 190.27
1st Resistance Point 188.59
Last Price 186.92
1st Support Level 183.77
2nd Support Level 180.63

See More

52-Week High 195.00
Last Price 186.92
Fibonacci 61.8% 167.04
Fibonacci 50% 158.40
Fibonacci 38.2% 149.76
52-Week Low 121.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar